REIT - Office
Compare Stocks
5 / 10Stock Comparison
CMCT vs GMRE vs NXRT vs CHCT vs NTST
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Residential
REIT - Healthcare Facilities
REIT - Retail
CMCT vs GMRE vs NXRT vs CHCT vs NTST — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Office | REIT - Healthcare Facilities | REIT - Residential | REIT - Healthcare Facilities | REIT - Retail |
| Market Cap | $3M | $94M | $760M | $502M | $1.73B |
| Revenue (TTM) | $114M | $148M | $252M | $122M | $176M |
| Net Income (TTM) | $-68M | $2M | $-32M | $6M | $185K |
| Gross Margin | -22.4% | 68.8% | 91.1% | 62.8% | 92.4% |
| Operating Margin | 3.1% | 24.9% | 11.5% | 31.3% | 27.7% |
| Forward P/E | — | 595.7x | — | 37.4x | 65.8x |
| Total Debt | $510M | $654M | $1.56B | $536M | $0.00 |
| Cash & Equiv. | $15M | $7M | $14M | $3M | $14M |
CMCT vs GMRE vs NXRT vs CHCT vs NTST — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 20 | May 26 | Return |
|---|---|---|---|
| Creative Media & Co… (CMCT) | 100 | 0.0 | -100.0% |
| Global Medical REIT… (GMRE) | 100 | 54.2 | -45.8% |
| NexPoint Residentia… (NXRT) | 100 | 72.3 | -27.7% |
| Community Healthcar… (CHCT) | 100 | 37.6 | -62.4% |
| NETSTREIT Corp. (NTST) | 100 | 112.7 | +12.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CMCT vs GMRE vs NXRT vs CHCT vs NTST
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CMCT ranks third and is worth considering specifically for dividends.
- 100.0% yield, vs NXRT's 7.0%
GMRE is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 5 yrs, beta 0.53, yield 63.5%
- 308.1% 10Y total return vs NXRT's 212.1%
- Lower volatility, beta 0.53, current ratio 0.03x
- Beta 0.53, yield 63.5%, current ratio 0.03x
Among these 5 stocks, NXRT doesn't own a clear edge in any measured category.
CHCT carries the broadest edge in this set and is the clearest fit for value and quality.
- Lower P/E (37.4x vs 65.8x)
- 5.0% margin vs CMCT's -59.4%
- 0.6% ROA vs CMCT's -7.9%, ROIC 1.6% vs 0.8%
NTST is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 30.0%, EPS growth 150.0%, 3Y rev CAGR 28.2%
- 30.0% FFO/revenue growth vs CMCT's -6.3%
- Beta 0.08 vs CMCT's 0.89
- +34.7% vs CMCT's -99.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 30.0% FFO/revenue growth vs CMCT's -6.3% | |
| Value | Lower P/E (37.4x vs 65.8x) | |
| Quality / Margins | 5.0% margin vs CMCT's -59.4% | |
| Stability / Safety | Beta 0.08 vs CMCT's 0.89 | |
| Dividends | 100.0% yield, vs NXRT's 7.0% | |
| Momentum (1Y) | +34.7% vs CMCT's -99.1% | |
| Efficiency (ROA) | 0.6% ROA vs CMCT's -7.9%, ROIC 1.6% vs 0.8% |
CMCT vs GMRE vs NXRT vs CHCT vs NTST — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
CMCT vs GMRE vs NXRT vs CHCT vs NTST — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NTST leads in 3 of 6 categories
CMCT leads 0 • GMRE leads 0 • NXRT leads 0 • CHCT leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — CHCT and NTST each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NXRT is the larger business by revenue, generating $252M annually — 2.2x CMCT's $114M. CHCT is the more profitable business, keeping 5.0% of every revenue dollar as net income compared to CMCT's -59.4%. On growth, NTST holds the edge at +27.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $114M | $148M | $252M | $122M | $176M |
| EBITDAEarnings before interest/tax | $23M | $95M | $125M | $82M | $133M |
| Net IncomeAfter-tax profit | -$68M | $2M | -$32M | $6M | $185,000 |
| Free Cash FlowCash after capex | -$40M | $19M | $79M | $60M | $106M |
| Gross MarginGross profit ÷ Revenue | -22.4% | +68.8% | +91.1% | +62.8% | +92.4% |
| Operating MarginEBIT ÷ Revenue | +3.1% | +24.9% | +11.5% | +31.3% | +27.7% |
| Net MarginNet income ÷ Revenue | -59.4% | +1.7% | -12.7% | +5.0% | +0.1% |
| FCF MarginFCF ÷ Revenue | -35.0% | +12.6% | +31.2% | +49.4% | +59.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -8.9% | +18.7% | +0.5% | +4.8% | +27.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.4% | -166.2% | 0.0% | +124.4% | +110.6% |
Valuation Metrics
Evenly matched — CMCT and CHCT each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 115.3x trailing earnings, GMRE trades at a 55% valuation discount to NTST's 258.4x P/E. On an enterprise value basis, GMRE's 8.3x EV/EBITDA is more attractive than NXRT's 18.6x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3M | $94M | $760M | $502M | $1.7B |
| Enterprise ValueMkt cap + debt − cash | $497M | $741M | $2.3B | $1.0B | $1.7B |
| Trailing P/EPrice ÷ TTM EPS | -0.09x | 115.29x | -23.77x | 227.13x | 258.38x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 595.67x | — | 37.40x | 65.77x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 4.42x |
| EV / EBITDAEnterprise value multiple | 14.07x | 8.35x | 18.63x | 16.22x | 12.53x |
| Price / SalesMarket cap ÷ Revenue | 0.03x | 0.68x | 3.02x | 4.14x | 8.85x |
| Price / BookPrice ÷ Book value/share | 0.02x | 0.17x | 2.53x | 1.10x | 1.20x |
| Price / FCFMarket cap ÷ FCF | — | — | 9.09x | 8.90x | 15.76x |
Profitability & Efficiency
NTST leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
CHCT delivers a 1.4% return on equity — every $100 of shareholder capital generates $1 in annual profit, vs $-24 for CMCT. GMRE carries lower financial leverage with a 1.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to NXRT's 5.18x. On the Piotroski fundamental quality scale (0–9), NTST scores 6/9 vs CMCT's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -24.4% | +0.5% | -10.1% | +1.4% | +0.0% |
| ROA (TTM)Return on assets | -7.9% | +0.2% | -1.7% | +0.6% | +0.0% |
| ROICReturn on invested capital | +0.8% | +2.0% | +1.1% | +1.6% | +2.1% |
| ROCEReturn on capital employed | +1.1% | +5.3% | +1.5% | +2.8% | +2.1% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 | 4 | 5 | 6 |
| Debt / EquityFinancial leverage | 1.91x | 1.18x | 5.18x | 1.25x | — |
| Net DebtTotal debt minus cash | $494M | $647M | $1.5B | $533M | -$14M |
| Cash & Equiv.Liquid assets | $15M | $7M | $14M | $3M | $14M |
| Total DebtShort + long-term debt | $510M | $654M | $1.6B | $536M | $0 |
| Interest CoverageEBIT ÷ Interest expense | 0.03x | 1.14x | 0.47x | 1.15x | — |
Total Returns (Dividends Reinvested)
NTST leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NTST five years ago would be worth $11,744 today (with dividends reinvested), compared to $410 for CMCT. Over the past 12 months, NTST leads with a +34.7% total return vs CMCT's -99.1%. The 3-year compound annual growth rate (CAGR) favors NTST at 8.8% vs CMCT's -65.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -98.3% | +6.9% | +3.1% | +10.6% | +17.6% |
| 1-Year ReturnPast 12 months | -99.1% | +10.9% | -13.8% | +16.1% | +34.7% |
| 3-Year ReturnCumulative with dividends | -95.9% | +5.6% | -15.2% | -36.4% | +28.7% |
| 5-Year ReturnCumulative with dividends | -95.9% | -21.5% | -23.0% | -45.5% | +17.4% |
| 10-Year ReturnCumulative with dividends | -59.4% | +308.1% | +212.1% | +83.4% | +42.4% |
| CAGR (3Y)Annualised 3-year return | -65.5% | +1.8% | -5.3% | -14.0% | +8.8% |
Risk & Volatility
NTST leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NTST is the less volatile stock with a 0.08 beta — it tends to amplify market swings less than CMCT's 0.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NTST currently trades 97.0% from its 52-week high vs CMCT's 0.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.89x | 0.53x | 0.61x | 0.61x | 0.08x |
| 52-Week HighHighest price in past year | $1441.00 | $39.93 | $38.30 | $18.22 | $21.30 |
| 52-Week LowLowest price in past year | $3.60 | $29.05 | $23.79 | $13.23 | $15.24 |
| % of 52W HighCurrent price vs 52-week peak | +0.4% | +89.5% | +78.2% | +96.5% | +97.0% |
| RSI (14)Momentum oscillator 0–100 | 23.8 | 52.7 | 70.4 | 59.3 | 52.4 |
| Avg Volume (50D)Average daily shares traded | 3.9M | 147K | 213K | 227K | 1.2M |
Analyst Outlook
Evenly matched — CMCT and NXRT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: GMRE as "Buy", NXRT as "Hold", CHCT as "Hold", NTST as "Buy". Consensus price targets imply 11.9% upside for GMRE (target: $40) vs -9.8% for NXRT (target: $27). For income investors, CMCT offers the higher dividend yield at 100.00% vs NTST's 4.04%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | — | $40.00 | $27.00 | $18.50 | $22.03 |
| # AnalystsCovering analysts | — | 22 | 10 | 16 | 18 |
| Dividend YieldAnnual dividend ÷ price | +100.0% | +63.5% | +7.0% | +11.4% | +4.0% |
| Dividend StreakConsecutive years of raises | 0 | 5 | 12 | 11 | 0 |
| Dividend / ShareAnnual DPS | $23.89 | $22.70 | $2.11 | $2.00 | $0.83 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.6% | 0.0% | +1.0% | +0.4% | +0.0% |
NTST leads in 3 of 6 categories — strongest in Profitability & Efficiency and Total Returns. 3 categories are tied.
CMCT vs GMRE vs NXRT vs CHCT vs NTST: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CMCT or GMRE or NXRT or CHCT or NTST a better buy right now?
For growth investors, NETSTREIT Corp.
(NTST) is the stronger pick with 30. 0% revenue growth year-over-year, versus -6. 3% for Creative Media & Community Trust Corporation (CMCT). Global Medical REIT Inc. (GMRE) offers the better valuation at 115. 3x trailing P/E (595. 7x forward), making it the more compelling value choice. Analysts rate Global Medical REIT Inc. (GMRE) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CMCT or GMRE or NXRT or CHCT or NTST?
On trailing P/E, Global Medical REIT Inc.
(GMRE) is the cheapest at 115. 3x versus NETSTREIT Corp. at 258. 4x. On forward P/E, Community Healthcare Trust Incorporated is actually cheaper at 37. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CMCT or GMRE or NXRT or CHCT or NTST?
Over the past 5 years, NETSTREIT Corp.
(NTST) delivered a total return of +17. 4%, compared to -95. 9% for Creative Media & Community Trust Corporation (CMCT). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus CMCT's -59. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CMCT or GMRE or NXRT or CHCT or NTST?
By beta (market sensitivity over 5 years), NETSTREIT Corp.
(NTST) is the lower-risk stock at 0. 08β versus Creative Media & Community Trust Corporation's 0. 89β — meaning CMCT is approximately 1001% more volatile than NTST relative to the S&P 500. On balance sheet safety, Global Medical REIT Inc. (GMRE) carries a lower debt/equity ratio of 118% versus 5% for NexPoint Residential Trust, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CMCT or GMRE or NXRT or CHCT or NTST?
By revenue growth (latest reported year), NETSTREIT Corp.
(NTST) is pulling ahead at 30. 0% versus -6. 3% for Creative Media & Community Trust Corporation (CMCT). On earnings-per-share growth, the picture is similar: NETSTREIT Corp. grew EPS 150. 0% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Over a 3-year CAGR, NTST leads at 28. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CMCT or GMRE or NXRT or CHCT or NTST?
Global Medical REIT Inc.
(GMRE) is the more profitable company, earning 4. 8% net margin versus -33. 4% for Creative Media & Community Trust Corporation — meaning it keeps 4. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NTST leads at 25. 7% versus 7. 1% for CMCT. At the gross margin level — before operating expenses — NTST leads at 99. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CMCT or GMRE or NXRT or CHCT or NTST more undervalued right now?
On forward earnings alone, Community Healthcare Trust Incorporated (CHCT) trades at 37.
4x forward P/E versus 595. 7x for Global Medical REIT Inc. — 558. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GMRE: 11. 9% to $40. 00.
08Which pays a better dividend — CMCT or GMRE or NXRT or CHCT or NTST?
All stocks in this comparison pay dividends.
Creative Media & Community Trust Corporation (CMCT) offers the highest yield at 100. 0%, versus 4. 0% for NETSTREIT Corp. (NTST).
09Is CMCT or GMRE or NXRT or CHCT or NTST better for a retirement portfolio?
For long-horizon retirement investors, NETSTREIT Corp.
(NTST) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 08), 4. 0% yield). Both have compounded well over 10 years (NTST: +42. 4%, CMCT: -59. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CMCT and GMRE and NXRT and CHCT and NTST?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CMCT is a small-cap income-oriented stock; GMRE is a small-cap income-oriented stock; NXRT is a small-cap income-oriented stock; CHCT is a small-cap income-oriented stock; NTST is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.